ALLEN, J. B., D. BLATTER, G. B. CALANDRA u. R. L. WILDER (1983):
Sex hormonal effects on the severity of streptococcal cell wall-induced polyarthritis in the rat.
Arthritis Rheum. 26, 560-563
ANNESE, V., A. PIEPOLI, A. ANDRIULLI, G. NAPOLITANO, L. BISCEGLIA, L.
ZELANTE, u. P. GASPARINI (1998):
Polymorphism of motilin gene in patients with Crohn´s disease.
Dig. Dis. Sci. 43, 715-719
ARANDA, R., B. C. SYDORA, P. L. McALLISTER, S. W. BINDER, H. Y. YANG, S. R.
TARGAN u. M. KRONENBERG (1997):
Analysis of intestinal lymphocytes in mouse colitis mediated by transfer of CD4+, CD45RBhigh T cells to SCID recipients.
J. Immunol. 158, 3464-3473
ARNOLD, G. L., H. PATEL, M. BEAVES u. H. BOYD (1999):
Ciprofloxacin in active Crohn´s disease: preliminary report of a six month randomized placebo controlled study.
Gastroenterology 116 (Suppl.), A664
BACHVAROV, D.R., M. LANDRY, S. HOULE, P. PARÉ u. F. MARCEAU (1998):
Altered frequency of a promoter polymorphic allele of the kinin B1 receptor gene in inflammatory bowel disease.
Gastroenterology 115, 1045-1048
BALDWIN, C. T., L. A. FARRER, R. ADAIR, R. DHARMAVARAM, S. JIMENEZ u. L.
ANDERSON (1995):
Linkage of early-onset osteoarthritis and chondrocalcinosis to human chromosome 8q.
Am. J. Hum. Genet. 56, 692-697
BANGARU, B., R. MORECKI, J. H. GLASER, L. M. GARTNER u. M. S. HORWITZ (1980):
Comparative studies of biliary atresia in the human newborn and reovirus-induced cholangitis in weanling mice.
Lab. Invest. 43, 452-462
BARIBAULT, H., J. PENNER, R. V. IOZZO u. M. WILSON-HEINER (1994):
Colorectal hyperplasia and inflammation in keratin 8-deficient FVB/N mice.
Genes Dev. 8, 2964-2973
BERG, D. J., N. DAVIDSON, R. KÜHN, W. MÜLLER, S. MENON, G. HOLLAND, L.
THOMPSON-SNIPES, M. W. LEACH u. D. RENNICK (1996):
Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4+ TH1-like responses.
J. Clin. Invest. 98, 1010-1020
BIANCHI, C. A. (1984):
Cutaneous manifestations of the malabsorption syndrome.
Med. Cutan. Ibero Lat. Am. 12, 277-285
BOIRIVANT, M., I. J. FUSS, A. CHU u. W. STROBER (1998):
Oxazolone colitis: a murine model of T helper cell type 2 colitis treatable with antibodies to interleukin 4.
J. Exp. Med. 188, 1929-1939
BRANDWEIN, S. L., R. P. McCABE, Y. CONG, K. B. WAITES, B. U. RIDWAN, P. A.
DEAN, T. OHKUSA, E. H. BIRKENMEIER, J. P. SUNDBERG u. C. O. ELSON (1997):
Spontaneously colitic C3H/HeJBir mice demonstrate selective antibody reactivity to antigens of the enteric bacterial flora.
J. Immunol. 159, 44-52
BRANT, S. R., Y. FU, C. T. FIELDS, R. BALTAZAR, G. RAVENHILL, M. R.
PICKLES, P. M. ROHAL, J. MANN, B. S. KIRSCHNER, E. W. JABS, T. M.
BAYLESS, S. B. HANAUER u. J. H. CHO (1998):
American families with Crohn´s disease have strong evidence for linkage to chromosome 16 but not chromosome 12.
Gastroenterology 115, 1056-1061
BRANT, S. R., R. RAMOS, D. BONEN, S. LUBINSKI, G. RAVENHILL, P. ROHAL, S.
LEE u. J. CHO (2000):
Limited genetic evidence for mdr1 as a candidate gene for inflammatory bowel disease.
Gastroenterology 118, A331
BRISTOL, L. A., S. K. DURUM u. S. P. EISENBERG (1993):
Differential regulation of group A streptococcal peptidoglycan-polysaccharide (PG-APS)-stimulated macrophage production of IL-1 by rat strains susceptible and resistant to PG-APS-induced arthritis.
Cell. Immunol. 149, 130-143
BRISTOL, I. J., M. A. FARMER, Y. CONG, X. X. ZHENG, T. B. STROM, C. O.
ELSON, J. P. SUNDBERG u. E. H. LEITER (2000):
Heritable susceptibility for colitis in mice induced by IL-10 deficiency.
Inflamm. Bowel Dis. 6, 290-302
BROBERGER, O. u. P. PERLMANN (1959):
Autoantibodies in human ulcerative colitis.
J. Exp. Med. 110, 657-674
BROOME, U., R. LOFBERG, K. LUNDQVIST u. B. VERESS (1995):
Subclinical time span of inflammatory bowel disease in patients with primary sclerosing cholangitis.
Dis. Colon Rectum 38, 1301-1305
BUSH, T. G., T. C. SAVIDGE, T. C. FREEMAN, H. J. COX, E. A. CAMPBELL, L.
MUCKE, M. H. JOHNSON u. M. V. SOFRONIEW (1998):
Fulminant jejuno-ileitis following ablation of enteric glia in adult transgenic mice.
Cell 93, 189-201
CALKINS, B. M. u. A. I. MENDELHOFF (1995):
The epidemiology of idiopathic inflammatory bowel disease.
In: KIRSNER, J.B. u. R.G. SHORTER (Hrsg.): Inflammatory bowel disease Williams & Wilkins, Baltimore, S. 31-68
CANGEMI, J. R., R. H. WIESNER, S. J. BEAVER u. J. LUDWIG (1989):
The effect of proctocolectomy for chronic ulcerative colitis on the natural history of primary sclerosing cholangitis.
Gastroenterology 96, 790-794
CAVANAUGH, J. A., D. F. CALLEN, D. R. WILSON, P. M. STANFORD, M. E.
SRAML, M. GORSKA, J. CRAWFORD, S. A. WHITMORE, C. SHLEGEL, S. FOOTE, M. KOHONEN-CORISH u. P. PAVLI (1998):
Analysis of Australian Crohn’s disease pedigrees refines the localization for susceptibility to inflammatory bowel disease on chromosome 16.
Ann. Hum. Genet. 62, 291-298
CHAPMAN, R. W., M. COTTONE, W. S. SELBY, H. A. SHEPHERD, S. SHERLOCK u. D. P. JEWELL (1986):
Serum autoantibodies in ulcerative colitis and primary sclerosing cholangitis.
Gut 27, 86-91
CHAPMAN, R. W., Z. VARGHESE, R. GAUL, G. PATEL, N. KIKINON u. S.
SHERLOCK (1983):
Association of primary sclerosing cholangitis with HLA-B8.
Gut 24, 38-41
CHIODINI, R. J., H. J. V. KRUININGEN, W. R. THAYER, R. S. MERKAL u. J. A.
COUTOU (1984):
Possible role of mycobacteria in inflammatory bowel disease. I. An unclassified Mycobacterium species isolated from patients with Crohn´s disease.
Dig. Dis. Sci. 29, 1073-1079
CHO, J. H., D. L. NICOLAE, L. H. GOLD, C. T. FIELDS, M. C. LABUDA, P. M.
ROHAL, M. R. PICKLES, L. QIN, Y. FU, J. S. MANN, B. S. KIRSCHNER, E. W.
JABS, J. WEBER, S. B. HANAUER, T. M. BAYLESS u. S. R. BRANT (1998):
Identification of novel susceptibility loci for inflammatory bowel disease on chromosome 1p, 3q, and 4q: evidence for epistasis between 1p and IBD1.
Proc. Natl. Acad. Sci. USA 95, 7502-7507
CHO, J. H., D. L. NICOLAE, R. RAMOS, C. T. FIELDS, K. RABENAU, S.
CORRADINO, S. R. BRANT, R. ESPINOSA, M. LeBEAU, S. B. HANAUER, J.
BODZIN u. D. K. BONEN (2000):
Linkage and linkage disequilibrium in chromosome band 1p36 in American chaldeans with inflammatory bowel disease.
Hum. Mol. Genet. 9, 1425-1432
CLEGG, C. H., J. T. RULFFES, H. S. HAUGEN, I. H. HOGGATT, A. ARUFFO, S. K.
DURHAM, A. G. FARR u. D. HOLLENBAUGH (1997):
Thymus dysfunction and chronic inflammatory disease in gp39 transgenic mice.
Int. Immunol. 9, 1111-1122
COLOMBEL, J. F., M. LEMANN, M. CASSAGNOU, Y. BOUHNIK, B. DUCLOS, J. L.
DUPAS, B. NOTTEGHEM u. J. Y. MARY (1999):
A controlled trial comparing ciprofloxacin with mesalazine for the treatment of active Crohn´s disease.
Am. J. Gastroenterol. 94, 674-678
CONG, Y., S. L. BRANDWEIN, R. P. McCABE, A. LAZENBY, E. H. BIRKENMEIER, J. P. SUNDBERG u. C. O. ELSON (1998):
CD4+ T cells reactive to enteric bacterial antigens in spontaneously colitic C3H/HeJBir mice: increased helper cell type 1 response and ability to transfer disease.
J. Exp. Med. 187, 855-864
CONTRACTOR, N. V., H. BASSIRI, T. REYA, A. Y. PARK, D. C. BAUMGART, M. A.
WASIK, S. G. EMERSON u. S. R. CARDING (1998):
Lymphoid hyperplasia, autoimmunity, and compromised intestinal intraepithelial lymphocyte development in colitis-free gnotobiotic IL-2-deficient mice.
J. Immunol. 60, 385-394
CORNÉLIS, F., S. FAURÉ, M. MARTINEZ, J.-F. PRUD’HOMME, P. FRITZ, C. DIB., H. ALVES, P. BARRERA, N. DE VRIES, A. BALSA, D. PASCUAL-SALCEDO, K.
MAENAUT, R. WESTHOVENS, P. MIGLIORINI, T. H. TRAN, A. DELAYE, N.
PRINCE, C. LEFEVRE, G. THOMAS, M. POIRIER, S. SOUBIGOU, O. ALIBERT, S.
LASBLEIZ, S. FIOUX, C. BOUCHIER, F. LIOTE, M. N. LOSTE, V. LEPAGE, D.
CHARRON, G. GYAPAY, A. LOPEZ-VAZ, D. KUNTZ, T. BARDIN u. J.
WEISSENBACH (1998):
New susceptibility locus for rheumathoid arthritis suggested by a genome-wide linkage study.
Proc. Natl. Acad. Sci. USA 95, 10746-10750
CURRAN, M .E., K. F. LAU, J. HAMPE, S. SCHREIBER, S. BRIDGER, A. J. S. MAC PHERSON, L. R. CARDON, H. SAKUL, T. J. R. HARRIS, P. STOKKERS, S. J. H.
VAN DEVENTER, M. MIRZA, A. RAEDLER, W. KRUIS, U. MECKLER, D. THEUER, T. HERRMANN, P. GIONCHETTI, J. LEE, C. MATHEW u. J. LENNARD-JONES (1998):
Genetic analysis of inflammatory bowel disease in a large European cohort supports linkage to chromosomes 12 and 16.
Gastroenterology 115, 1066-1071
DAHLMAN, I., J. C. LORENTZEN, K. L. DE GRAAF, A. STEFFERL, C. LININGTON, H. LUTHMAN u. T. OLSSON (1998):
Quantitative trait loci disposing for both experimental arthritis and encephalomyelitis in the DA rat; impact on severity of myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis and antibody isotype pattern.
Eur. J. Immunol. 28, 2188-2196
DAHLMAN, I., E. WALLSTRÖM, H. JIAO, H. LUTHMAN, T. OLSSON u. R.
WEISSERT (2001):
Polygenic control of autoimmune peripheral nerve inflammation in rat.
J. Neuroimmunol. 119, 166-174
DAHLMAN, I., E. WALLSTRÖM, R. WEISSERT, M. STORCH, B. KORNEK, L.
JACOBSSON, C. LININGTON, H. LUTHMAN, H. LASSMANN u. T. OLSSON (1999):
Linkage analysis of myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis in the rat identifies a locus controlling demyelination on chromosome 18.
Hum. Mol. Genet. 8, 2183-2190
DEW, M. J., H. THOMPSON u. R. N. ALLAN (1979):
The spectrum of hepatic dysfunction in inflammatory bowel disease.
Q. J. M. 48, 113-135
DIANDA, L., A. M. HANBY, N. A. WRIGHT, A. SEBESTENY, A. C. HAYDAY u. M. J.
OWEN (1997):
T cell receptor-alpha beta-deficient mice fail to develop colitis in the absence of a microbial environment.
Am. J. Pathol. 150, 91-97
DRACHEVA, S. V., E. F. REMMERS, P. S. GULKO, Y. KAWAHITO, R. E.
LONGMAN, V. R. REESE, G. W. CANNON, M. M. GRIFFITHS u R. L. WILDER (1999):
Identification of a new quantitative trait locus on chromosome 7 controlling disease severity of collagen-induced arthritis in rats.
Immunogenetics 49, 787-791
DRENICK, E. J., J. FISLER u. D. JOHNSON (1982):
Hepatic steatosis after intestinal bypass – prevention and reversal by metronidazole, irrespective of protein-calorie malnutrition.
Gastroenterology 82, 535-548
DUERR, R. H. (1996):
Genetics of inflammatory bowel disease.
Inflamm. Bowel Dis. 2, 48-60
DUERR, R. H., M. M. BARMADA, L. ZHANG, S. DAVIS, R. A. PRESTON, L. J.
CHENSNY, J. L. BROWN, G. D. EHRLICH, D. E. WEEKS u. C. E. ASTON (1998):
Linkage and association between inflammatory bowel disease and a locus on chromosome 12.
Am. J. Hum. Genet. 63, 95-100
DUERR, R. H., M. M. BARMADA, L. ZHANG, R. PFÜTZER u. D. E. WEEKS (2000):
High-density genome scan in Crohn disease shows confirmed linkage to chromosome 14q11-12.
Am. J. Hum. Genet. 66, 1857-1862
ELSON, C. O. (1999):
Experimental models of intestinal inflammation. new insights into mechanisms of mucosal homeostasis.
In: OGRA, P.L., J. MESTECKY, M.E. LAMM, W. STROBER, J. R. McGHEE u. J.
BIENENSTOCK (Hrsg.): Handbook of Mucosal Immunoloy.
San Diego, Academic Press, S. 1007-1024
ELSON, C. O., K. W. BEAGLEY, A. T. SHARMANOV, K. FUJIHASHI, H. KIYONO, G. S. TENNYSON, Y. CONG, C. A. BLACK, B. W. RIDWAN u. J. R. McGHEE (1996):
Hapten-induced model of murine inflammatory bowel disease: mucosal immune responses and protection by tolerance.
J. Immunol. 157, 2174-2185
ELSON, C. O., R. B. SARTOR, G. S. TENNYSON u. R. H. RIDDELL (1995):
Experimental models of inflammatory bowel disease.
Gastroenterology 109, 1344-1367
FARMER, M. A., J. P. SUNDBERG, I. J. BRISTOL, G. A. CHURCHILL, R. LI, C. O.
ELSON u. E. H. LEITER (2001):
A major quantitative trait locus on chromosome 3 controls colitis severity in IL-10-deficient mice.
Proc. Natl. Acad. Sci. USA 98, 13820-13825
FIOCCHI, C. (1998):
Inflammatory bowel disease: etiology and pathogenesis.
Gastroenterology 115, 182-205
FUJITA, K., S. NAITO, N. OKABE u. T. YAO (1984):
Immunological studies in Crohn´s disease. 1. Association with HLA systems in the Japanese.
J. Clin. Lab. Immunol. 14, 99-102
FURUYA, T., J. L. SALSTROM, S. McCALL-VINING, G. W. CANNON, B. JOE, E. F.
REMMERS, M. M. GRIFFITHS u. R. L. WILDER (2000):
Genetic dissection of a rat model for rheumatoid arthritis: significant gender influences on autosomal modifier loci.
Hum. Mol. Genet. 9, 2241-2250
GIONCHETTI, P., F. RIZZELLO, A. FERRIERI, A. VENTURA, C. BRIGNOLA, M.
FERRETTI, S. PERUZZO, M. MIGLIOLI u. M. CAMPIERI (1999):
Rifaximin in patients with moderate or severe ulcerative colitis refractory to steroid-treatment: a double-blind, placebo-controlled trial.
Dig. Dis. Sci. 44, 1220-1221
GREENBLOOM, S. L., A. H. STEINHART u. G. R. GREENBERG (1998):
Combination of ciprofloxacin and metronidazole for active Crohn´s disease.
Can. J. Gastroenterol. 12, 53-56
GREENSTEIN, A. J., H. D. JANOWIZ u. D. B. SACHAR (1976):
The extra-intestinal complications of Crohn´s disease and ulcerative colitis. A study of 700 patients.
Medicine 55, 401-412
GREGORY, B. u. V. C. HO (1992):
Cutaneous manifestations of gastrointestinal disorders.
J. Am. Acad. Dermatol. 26, 371-383
GRIFFITHS, M. M., J. WANG, B. JOE, S. DRACHEVA, Y. KAWAHITO, J. S.
SHEPARD, V. R. REESE, S. McCALL-VINING, A. HASHIRAMOTO, G. W.
CANNON, E. F. REMMERS u. R. L. WILDER (2000):
Identification of four new quantitative trait loci regulating arthritis severity and one new quantitative trait locus regulating autoantibody production in rats with collagen-induced arthritis.
Arthritis Rheum. 43, 1278-1289
GUMP, D., E. CAUL, O. EADE, H. GREENBERG, A. KAPIKIAN, B. MACPHERSON, P. MITCHELL, K. PARENT, S. RICHMOND u. W. BEEKEN (1981):
Lymphocytotoxic and microbial antibodies in Crohn´s disease and matched controls.
Anton. Leeuw. 47, 455-464
HAMMER, R. E., S. D. MAIKA, J. A. RICHARDSON, J. P. TANG u. J. D. TAUROG (1990):
Spontaneous inflammatory disease in transgenic rats expressing HLA-B27 and human beta2 microglobulin: an animal model of HLA-B27-associated human disorders.
Cell 63, 1099-1112
HAMPE, J., S. SCHREIBER, S. H. SHAW, K. F. LAU, S. BRIDGER, A. J. S.
MACPHERSON, L. R. CARDON, H. SAKUL, T. J. R. HARRIS, A. BUCKLER, J.
HALL, P. STOKKERS, S. J. H. VAN DEVENTER, P. NÜRNBERG, M. M. MIRZA, J.
C. W. LEE, J. E. LENNARD-JONES, C. G. MATHEW u. M. E. CURRAN (1999a):
A genomewide analysis provides evidence for novel linkages in inflammatory bowel disease in a large European cohort.
Am. J. Hum. Genet. 64, 808-816
HAMPE, J., S. H. SHAW, R. SAIZ, N. LEYSENS. A. LANTERMANN, S.
MASCHERETTI, N. J. LYNCH, A. J. S. MACPHERSON, S. BRIDGER, S. VAN DEVENTER, P. STOKKERS, P. MORIN, M. M. MIRZA, A. FORBES, J. E.
LENNARD-JONES, C. G. MATHEW, M. E. CURRAN u. S. SCHREIBER (1999b):
Linkage of inflammatory bowel disease to human chromosome 6p.
Am. J. Hum. Genet. 65, 1647-1655
HANS, W., J. SCHÖLMERICH, V. GROSS u. W. FALK (2000):
The role of the resident intestinal flora in acute and chronic dextran sulfate sodium-induced colitis in mice.
Eur. J. Gastroenterol. Hepatol. 12, 267-273
HAYCOCK, K. A., J. ROTH, J. GAGNON, W. F. FINZER u. C. SOPER (1992):
Stat View.
Abacus Concepts, Inc., Berkeley, CA
HEDRICH, H. J. (1990):
Mutant genes and polymorphic loci of the laboratory rat.
In: HEDRICH, H. J., (Hrsg.): Genetic monitoring of inbred strains of rats.
Stuttgart, Gustav Fischer Verlag, S. 289-409
HELPHINGSTINE, C. J., D. J. HENTGES, B. J. CAMPBELL, J. BUTT, u. J. T.
BARETT (1979):
Antibodies detectable by counterimmunoelectrophoresis against Bacteroides antigens in serum of patients with inflammatory bowel disease.
J. Clin. Microbiol. 9, 373-378
HERFARTH, H. H., S. P. MOHANTY, H. C. RATH, S. TONKONOGY u. R. B.
SARTOR (1996):
Interleukin 10 suppresses experimental chronic, granulomatous inflammation induced by bacterial cell wall polymers.
Gut 39, 836-845
HERMISTON, M. L. u. J. I. GORDON (1995):
Inflammatory bowel disease and adenomas in mice expressing a dominant negative N-cadherin.
Science 270, 1203-1207
HOFMEISTER, A., H. L. NEIBERGS, R. M. POKORNY u. S. GALANDIUK (1997):
The natural resistance-associated macrophage protein gene is associated with Crohn’s disease.
Surgery 122, 173-179
HOLLANDER, G. A., S. J. SIMPSON, E. MIZOGUCHI, A. NICHOGIANNOPOULOU, J. SHE, J. C. GUTIERREZ-RAMOS, A. K. BHAN, S. J. WANG, B. TERHORST u. C.
TERHORST (1995):
Severe colitis in mice with aberrant thymic selection.
Immunity 3, 27-38
HORLEY, K. J., C. CARPENITO, B. BAKER u. F. TAKEI (1989):
Molecular cloning of murine intercellular adhesion molecule (ICAM-1).
EMBO J. 10, 2889-2896
HUGOT, J. P, M. CHAMAILLARD, H. ZOUALI, S. LESAGE, J. P. CEZARD, J.
BELAICHE, S. ALMER, C. TYSK, C. A. O′MORAIN, M. GASSULL, V. BINDER, Y.
FINKEL, A. CORTOT, R. MODIGLIANI, P. LAURENT-PUIG, C. GOWER-ROUSSEAU, J. MACRY, J. F. COLOMBEL, M. SAHBATOU u. G. THOMAS (2001):
Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn′s disease.
Nature 411, 599-603
HUGOT, J. P., P. LAURENT-PUIG, C. GOWER-ROUSSEAU, J. M. OLSON, J. C.
LEE, L. BEAUGERIE, I. NAOM, J. -.L. DUPAS, A. VAN GOSSUM, M. ORHOLM, C.
BONAITI-PELLIE, J. WEISSENBACH, C. G. MATHEW, J. E. LENNARD-JONES, A.
CORTOT, J. - F. COLOMBEL u. G. THOMAS (1996):
Mapping of a susceptibility locus for Crohn's disease on chromosome 16.
Nature 379, 821-823
JACOB, H. J., D. M. BROWN, R. K. BUNKER, M. J. DALY, V. J. DZAU, G.
GOODMAN, G. KOIKE, V. KREN, T. KURTZ, A. LERNMARK, G. LEVAN, J. MAO, A.
PETTERSON, M. PRAVENEC, J. S. SIMON, C. SZPIRER, J. SZPIRER, M. R.
TROLLIET, E. S. WINER u. E. S. LANDER (1995):
A genetic linkage map of the laboratory rat, Rattus norvegicus.
KLÖTING, I. u. P. KOVACS (1998a):
Genes of the immune system cosegregate with the age at onset of diabetes in the BB/OK rat.
Biochem. Biophys. Res. Commun. 242, 461-463
KLÖTING, I. u. P. KOVACS (1998b):
Phenotypic differences between diabetes-prone BB rat sublines cosegregate with loci on chromosomes X and 10.
Biochem. Mol. Biol. Int. 45, 865-870
KONTOYIANNIS, D., M. PASPARAKIS, T. T. PIZARRO, F. COMINELLI u. G.
KOLLIAS (1999):
Impaired on/off regulation of TNF biosynthesis in mice lacking TNF AU-rich elements:
implications for joint and gut-associated immunopathologies.
Immunity 10, 387-398
KROOK, A., B. LINDSTROM, J. KJELLANDER, G. JARNEROT u. L. BODIN (1981):
Relation between concentrations of metronidazole and Bacteroides spp. in faeces of patients with Crohn´s disease and healthy individuals.
J. Clin. Pathol. 34, 645-650
KRUGLYAK, L. u. E. S. LANDER (1995):
A nonparametric approach for mapping quantitative trait loci.
Genetics 139, 1421-1428
KÜHN, R., J. LÖHLER, D. RENNICK, K. RAJEWSKY u. W. MÜLLER (1993):
Interleukin-10-deficient mice develop chronic entercolitis.
Cell 75, 263-274
LANDER, E. S. u. D. BOTSTEIN (1989):
Mapping mendelian factors underlying quantitative traits using RFLP linkage maps.
Genetics 121, 185-199
LANDER, E. u. L. KRUGLYAK (1995):
Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results.
Nat. Genet. 11, 241-247
LAWRANCE, I. C., C. FIOCCHI u. S. CHAKRAVARTI (2001):
Ulcerative colitis and Crohn´s disease: distinctive gene expression profiles and novel susceptibility candidate genes.
Hum. Mol. Genet. 10, 445-456
LICHTMAN, S. N., J. KEKU, J. H. SCHWAB u. R. B. SARTOR (1991):
Hepatic injury associated with small bowel bacterial overgrowth in rats is prevented by metronidazole and tetracycline.
Gastroenterology 100, 513-519
LICHTMAN, S. N., J. WANG, R. B. SARTOR, C. ZHANG, D. E. BENDER, F. G.
DALLDORF u. J. H. SCHWAB (1995):
Reactivation of arthritis induced by small bowel bacterial overgrowth in rats: role of cytokines, luminal bacteria and bacterial polymers.
Infect. Immun. 63, 2295-2301
LINDOR, K. D., R. H. WIESNER u. N. F. LaRUSSO (1987):
Recent advances in the management of primary sclerosing cholangitis.
Semin. Liver Dis. 7, 322-327
LISTWAK, S., R. M. BARRIENTOS, G. KOIKE, S. GHOSH, M. GOMEZ, B.
MISIEWICZ u. E. M. STERNBERG (1999):
Identification of a novel inflammation-protective locus in the Fischer rat.
Mamm. Genome 10, 362-365
LORENTZEN, J. C., A. GLASER, L. JACOBSSON, J. GALLI, H. FAKHRAI-RAD, L.
KLARESKOG u. H. LUTHMAN (1998):
Identification of rat susceptibility loci for adjuvant-oil-induced arthritis.
Proc. Natl. Acad. Sci. 95, 6383-6387
LOUGHLIN, J., Z. MUSTAFA, C. IRVEN, A. SMITH, A. J. CARR, B. SYKES u. K.
CHAPMAN (1999):
Stratification analysis of an osteoarthritis genome screen: suggestive linkage to chromosomes 4, 6 and 16.
Am. J. Hum. Genet. 65, 1795-1798
MA, Y., J. D. OHMEN, Z. LI, L. G. BENTLEY, C. McELREE, S. PRESSMAN, S. R.
TARGAN, N. FISCHEL-GHODSIAN, J. I. ROTTER u. H. YANG (1999):
A genome-wide search identifies potential new susceptibility loci for Crohn’s disease.
Inflamm. Bowel Dis. 5, 271-278
MACCAY, K., S. EYRE, A. MYERSCOUGH, A. MILICIC, A. BARTON, S.LAVAL, J.
BARRETT, D. LEE, S. WHITE, S. JOHN, M. A. BROWN, J. BELL, A. SILMAN, W.
OLLIER, P. WORDSWORTH u. J. WORTHINGTON (2002):
Whole-genome linkage analysis of rheumatoid arthritis susceptibility loci in 252 affected sibling pairs in the United Kingdom.
Arthritis Rheum. 46, 632-639
MADSEN, K. L., J. S. DOYLE, M. M. TAVERNINI, L. D. JEWELL, R. P. RENNIE u.
R. N. FEDORAK (2000):
Antibiotic therapy attenuates colitis in interleukin 10 gene-deficient mice.
Gastroenterology 118, 1094-1105
MÄHLER, M., I. J. BRISTOL, E. H. LEITER, E. H. BIRKENMEIER, C. O. ELSON u. J.
P. SUNDBERG (1998):
Differential susceptibility of inbred mouse strains to dextran sulfate sodium-induced colitis.
Am. J. Physiol. 274, G544-G551
MÄHLER, M., I. J. BRISTOL, J. P. SUNDBERG, G. A. CHURCHILL, E. H.
BIRKENMEIER, C. O. ELSON u. E. H. LEITER (1999):
Genetic analysis of susceptibility to dextran sulfate sodium-induced colitis in mice.
Genomics 55, 147-156
MÄHLER, M., C. MOST, S. SCHMIDTKE, J. P. SUNDBERG, R. LI, H. J. HEDRICH u. G. A. CHURCHILL (2002):
Genetics of colitis susceptibility in IL-10-deficient mice: backcross versus F2 results contrasted by principal component analysis.
Genomics 80, 274-282
MASON, J. C., H. YARWOOD, A. TARNOK, K. SUGARS, A. A. HARRISON, P. J.
ROBINSON u. D. O. HASKARD (1996):
Human Thy-1 is cytokine-inducible on vascular endothelial cells and is a signaling molecule regulated by protein kinase C.
J. Immunol. 157, 874-883
MATSUMOTO, S., Y. OKABE, H. SETOYAMA, K. TAKAYAMA, J. OHTSUKA, H.
FUNAHASHI, A. IMAOKA, Y. OKADA u. Y. UMESAKI (1998):
Inflammatory bowel disease-like enteritis and caecitis in a senescence accelerated mouse P1/Yit strain.
Gut 43, 71-78
MATSUZAWA, J., K. SUGIMURA, Y. MATSUDA, M. TAKAZOE, K. ISHIZUKA, T.
MOCHIZUKI, S. S. SEKI, O. YONEYAMA, H. BANNAI, K. SUZUKI, T. HONMA u. H.
ASAKURA (2003):
Association between K469E allele of intercellular adhesion molecule 1 gene and inflammatory bowel disease in a Japanese population.
Gut 52, 75-78
McCALL, R. D., J. S. HASKILL, E. M. ZIMMERMANN, P. K. LUND, R. C.
THOMPSON u. R. B. SARTOR (1994):
Tissue interleukin-1 and IL-1 receptor antagonist expression in enterocolitis in resistant and susceptible rats.
Gastroenterology 106, 960-972
MEENAN, J. (1995):
An overview of the immunological basis of inflammatory bowel disease and its therapy.
In: TYTGAT, G. N. J., J. F. W. M. BARTELSMAN, S. J. H. VAN DEVENTER (Hrsg.):
Inflammatory bowel disease
Kluwer Academic Publishers, Dordrecht, Bosten, London, S. 1-24
MEULENBELT, I., C. BIJKERK, H. S. MIEDEMA, F. C. BREEDVELT, A. HOFMAN, H. A. VALKENBURG, H. A. POLS, P. E. SLAGBOOM u. C. M. VAN DUIJN (1998):
A genetic association study of the IGF-1 gene and radiologic osteoarthritis in a population-based cohort study.
Ann. Rheum. Dis. 57, 371-374
MILLER, A. M., P. R. ELLIOTT, W. CONNELL, P. V. DESMOND u. A. J. D’APICE (2000):
A novel model of ulcerative colitis based on genetic modification of the gylcosylation of colonic mucins.
Gastroenterlogy 118, A687
MINUK, G. Y., N. RASCANIN, R. W. PAUL, P. W. K. LEE, K. BUCHAN u. J. K.
KELLY (1987):
Reovirus type 3 infection in patients with primarybiliary cirrhosis and primary sclerosing chalangitis.
J. Hepatol. 5, 8-13
MOMBAERTS, P., E. MIZOGUCHI, M. J. GRUSBY, L. H. GLIMCHER, A. K. BHAN u.
S. TONEGAWA (1993):
Spontaneous development of inflammatory bowel disease in T cell receptor mutant mice.
Cell 75, 275-282
MONSEN, U., J. SORSTAD, G. HELLERS u. C. JAHANSSON (1990):
Extracolonic diagnoses in ulcerative colitis: an epidemiological study.
Am. J. Gastroenterol. 85, 711-716
MOST, C. (2001):
Untersuchungen zur genetischen Disposition für chronische Darmentzündungen bei der IL10-defizienten Maus.
Tierärztliche Hochschule Hannover, Diss.
MURPHY, K. M., A. B. HEIMBERGER u. D. Y. LOH (1990):
Induction by antigen of intrathymic apoptosis of CD4+ CD8+ TCRLO thymocytes in vivo.
NAPARSTEK, Y. u. P. H. PLOTZ (1993):
The role of autoantibodies in autoimmune disease.
Annu. Rev. Immunol. 11, 79-104
OGURA, Y., D. K. BONEN, N. INOHARA, D. L. NICOLAE, F. F. CHEN, R. RAMOS, H. BRITTON, T. MORAN, R. KARALIUSKAS, R. H. DUERR, J. P. ACHKAR, S. R.
BRANT, T. M. BAYLESS, B. S. KIRSCHNER, S. B. HANAUER, G. NUNEZ u. J. H.
CHO (2001):
A frameshift mutation in NOD2 associated with susceptibility to Crohn′s disease.
Nature 411, 603-606
OHKUSA, T., M. YAMADA, T. TAKENAGA, C. KITAZUME, N. YAMAMOTO, M.
SASABE, I. TAKASHIMIZU, Y. TAMURA, E. CAKAMOTO, H. KUROSAWA, et al.
(1987):
Protective effect of metronidazole in experimental ulcerative colitis induced by dextran sodium.
Nippon Shokakibyo Gakkai Zasshi 84, 2337-2346
OHMEN, J. D., H.-Y. YANG, K. K. YAMAMOTO, H.-Y. ZHAO, Y. MA, L. G.
BENTLEY, Z. HUANG, S. GERWEHR, S. PRESSMAN, C. McELREE, S. R.
TARGAN, J. I. ROTTER u. N. FISCHEL-GHODSIAN (1996):
Susceptibility locus for inflammatory bowel disease on chromosome 16 has a role in Crohn’s disease, but not in ulcerative coltitis.
Hum. Mol. Genet. 5, 1679-1684
OKAYASU, I., S. HATAKEYAMA, M. YAMADA, T. OHKUSA, Y. INAGAKI u. R.
NAKAYA (1990):
A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice.
Gastroenterology 98, 694-702
OLSSON, R., A. DANIELSSON, G. JARNEROT, E. LINDSTROM, L. LOOF, P.
ROLNY, B.-O. RYDEN, C. TYSK u. S. WALLERSTEDT (1991):
Prevalence of primary sclerosing cholangitis in patients with ulcerative colitis.
Gastroenterology 100, 1319-1323
ONDERDONK, A. B., J. A. RICHARDSON, R. E. HAMMER u. J. D. TAUROG (1998):
Correlation of cecal microflora of HLA-B27 transgenic rats with inflammatory bowel disease.
Infect. Immun. 66, 6022-6023
ORCHARD, T. R., J. SATSANGI, D. VAN HEEL, D. P. JEWELL (2000):
Genetics of inflammatory bowel disease: a reappraisal.
Scand. J. Immunol. 51, 10-17
ORHOLM, M., V. BINDER, T. I. A. SORENSEN, L. P. RASMUSSEN u. K. O. KYVIK (2000):
Concordance of inflammatory bowel disease among Danish twins. Results of a nationwide study.
Scand. J. Gastroenterol. 35, 1075-1081
PANWALA, C. W., J. C. JONES u. J. L. VINEY (1998):
A novel model of inflammatory bowel disease: mice deficient for the multiple drug resistance-gen, mdr1a, spontaneously develop colitis.
J. Immunol. 161, 5733-5744
PARKES, M., J. SATSANGI, G. M. LATHROP, J. I. BELL u. D. P. JEWELL (1996):
Susceptibilitiy loci in inflammatory bowel disease.
Lancet 348, 1588
PODOLSKY, D. K. (1991):
Inflammatory bowel disease.
N. Engl. J. Med. 325, 928-937
POKORNY, R. M., A. HOFMEISTER, S. GALANDIUK, A. B. DIETZ, N. D. COHEN u.
H. L. NEIBERGS (1997):
Crohn’s disease and ulcerative colitis are associated with the DNA repair gene MLH1.
Ann. Surg. 225, 718-725
POWRIE, F., M. W. LEACH, S. MAUZE, L. B. CADDLE u. R. L. COFFMAN (1993):
Phenotypically distinct subsets of CD4+ T cells induce or protect from chronic intestinal inflammation in C.B-17 scid mice.
Immunity 1, 553-562
PRANTERA, C., A. KOHN, F. ZANNONI, N. SPIMPOLO u. M. BONFA (1994):
Metronidazole plus ciprofloxacin in the treatment of active, refractory Crohn´s disease: results of an open study.
J. Clin. Gastroenterol. 19, 79-80
RATH, H. C., D. E. BENDER, L. C. HOLT, T. GRENTHER, J. D. TAUROG, R. E.
HAMMER u. R. B. SATOR (1995):
Metronidazole attenuates colitis in HLA-B27/human beta2 microglobulin transgenic rats: a pathogenic role for anaerobic bacteria.
Clin. Immunol. Immunopathol. 76, S45
RATH, H. C., H. H. HERFARTH, J. S. IKEDA, W. B. GRENTHER, T. E. HAMM Jr., E.
BALISH, J. D. TAUROG, R. E. HAMMER, K. H. WILSON u. .R. B. SARTOR (1996):
Normal luminal bacteria, especially Bacteroides species, mediate chronic colitis, gastritis, and arthritis in HLA-B27/human beta2 microglobulin transgenic rats.
J. Clin. Invest 98, 945-953
RATH, H. C., J. S. IKEDA, H.-J. LINDE, J. SCHÖLMERICH, K. H. WILSON u. R. B.
SARTOR (1999):
Varying cecal bacterial loads influences colitis and gastritis in HLA-B27 transgenic rats.
Gastroenterology 116, 310-319
RATH; H. C., M. SCHULTZ, L. A. DIELEMAN, H. KÖLBL, W. FALK, J.
SCHÖLMERICH u. R. B. SARTOR (1998):
Selective vs. broad spectrum antibiotics in the prevention and treatment of experimental colitis in two rodent models.
Gastroenterology 114 (Suppl.), A1067
RATH, H. C., M. SCHUTZ, R. FREITAG, L. A. DIELEMAN, F. LI, H.-J. LINDE, J.
SCHÖLMERICH u. R. B. SARTOR (2001):
Different subsets of enteric bacteria induce and perpetuate experimental colitis in rats and mice.
Infect. Immun. 69, 2277-2285
REMMERS, E. F., R. E. LONGMAN, Y. DU, A. O´HARE, G. W. CANNON, M. M.
GRIFFITHS u. R. L. WILDER (1996):
A genome scan localizes five non-MHC loci controlling collagen-induced arthritis in rats.
Nat. Genet. 14, 82-85
RIOUX, J. D., M. J. DALY, M. S. SILVERBERG, K. LINDBLAD, H. STEINHART, Z.
COHEN, T. DELMONTE, K. KOCHER, K. MILLER, S. GUSCHWAN, E. J.
KULBOKAS, S. O´LEARY, E. WINCHESTER, K. DEWAR, T. GREEN, V. STONE, C.
CHOW, A. COHEN, D. LANGELIER, G. LAPOINTE, D. GAUDET, J. FAITH, N.
BRANCO, S. B. BULL, R. S. McLEOD, A. M. GRIFFITHS, A. BITTON, G. R.
GREENBERG, E. S. LANDER, K. A. SIMINOVITCH u. T. J. HUDSON (2001):
Genetic variation in the 5q31 cytokine gene cluster confers susceptibility to Crohn disease.
Nat. Genet. 29, 223-228
RIOUX, J. D., M. S. SILVERBERG, M. J. DALY, A. H. STEINHART, R. S. McLEOD, A. M. GRIFFITHS, T. GREEN, T. S. BRETTIN, V. STONE, S. B. BULL, A. BITTON, C. N. WILLIAMS, G. R. GREENBERG, Z. COHEN, E. S. LANDER, T. J. HUDSON u.
K. A. SIMINOVITCH (2000):
Genomewide search in Canadian families with inflammatory bowel disease reveals two novel susceptibility loci.
Am. J. Hum. Genet. 66, 1863-1870
ROTH, M.-P., C. VIRATELLE, L. DOLBOIS, M. DELVERDIER, N. BOROT, L.
PELLETIER, P. DRUET, M. CLANET u. H. COPPIN (1999):
A genome-wide search identifies two susceptibility loci for experimental autoimmune encephalomyelitis on rat chromosomes 4 and 10.
J. Immunol. 162, 1917-1922
ROUSSOMOUSTAKAKI, J., J. SATSANGI, K. WELSH, E. LOUIS, G. FANNING, S.
TARGAN, C. LANDERS u. D. P. JEWELL (1997):
Genetic markers may predict disease behaviour in patients with ulcerative colitis.
Gastroenterology 112, 1845-1853
RUDOLPH, U., M. J. FINEGOLD, S. S. RICH, G. R. HARRIMAN, Y. SRINIVASAN, P. BRABET, G. BOULAY, A. BRADLEY u. L. BIRNBAUMER (1995):
Ulcerative colitis and adenocarcinoma of the colon in Gαi2-deficient mice.
Nat. Genet. 10, 143-150
RUTGEERTS, P., M. HIELE, G. GEBOES, M. PEETERS, F. PENNINCKX, R.
AERTS u. R. KERREMANA (1995):
Controlled trial of metronidazole treatment for prevention of Crohn´s recurrence after ileal resection.
Gastroenterology 108, 1617-1621
SADLACK, B., H. MERZ, H. SCHORLE, A. SCHIMPL, A. C. FELLER u. I. HORAK (1993):
Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene.
Cell 75, 253-261
SALMON, J. F., J. P. WRIGHT u. A. D. N. MURRAY (1991):
Ocular inflammation in Crohn´s disease.
Ophthalmology 98, 480-484
SARTOR, R. B. (1994):
Cytokines in intestinal inflammation: pathophysiological and clinical considerations.
Gastroenterology 106, 533-539
Gastroenterology 106, 533-539